Chief Technology Officer, Research and Development @ (October 2020 - Present)
Head, Pharmaceutical Sciences and Cell Therapies Translational Engine @ (January 2019 - October 2020)
Head, Pharmeceutical Sciences @ (October 2017 - January 2019)
Entrepreneur in Residence @ (July 2017 - October 2017)
Incubating...... @ Incubating (November 2016 - July 2017)
Founder @ 18bio (April 2017 - Present)
Vice President, Global Head Technical Research and Development, Cell- And Gene Therapies Unit @ (September 2013 - November 2016)
Vice President, Global Head Integrated Biologics Profiling @ Novartis Pharma Ag Novartis Intitutes for Biomedical Research (June 2011 - September 2013)
Senior Director @ (July 2008 - June 2011)
Director @ (June 2006 - July 2008)
Director @ (January 2000 - January 2006)
Postdoctoral Associate Department of Chemical Engineering @ (January 1998 - January 2000)
ph.d. Student @ (January 1993 - January 1998)
Stefan Wildt Education
Technische Universität Berlin
(Biotechnology)
1987-1992
Stefan Wildt Summary
Stefan Wildt, based in Cambridge, MA, US, is currently a Executive Chair at Alaya.bio. Stefan Wildt brings experience from previous roles at March Biosciences, Incubating, Takeda and Takeda Pharmaceuticals. Stefan Wildt holds a 1987 - 1992 Technische Universität Berlin. Stefan Wildt has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Stefan Wildt?
Find contact details for 700 million professionals.